Lopressor and Injection site mass - a phase IV clinical study of FDA data

Summary:

Injection site mass is reported as a side effect among people who take Lopressor (metoprolol tartrate), especially for people who are male, 60+ old, also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Injection site mass when taking Lopressor. It is created by eHealthMe based on reports of 32,072 people who have side effects when taking Lopressor from the FDA, and is updated regularly.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

What is Injection site mass?

Injection site mass is found to be associated with 832 drugs and 787 conditions by eHealthMe. Check the latest studies of Injection site mass.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

32,072 people reported to have side effects when taking Lopressor.
Among them, 31 people (0.1%) have Injection site mass.

Could Lopressor cause Injection site mass?

Among these 31 people:

What is the gender of people who have Injection site mass when taking Lopressor? *

female: 44.83 %
male: 55.17 %

What is the age of people who have Injection site mass when taking Lopressor? *

What are other drugs people take besides Lopressor? *

What are other side effects people have besides Injection site mass? *

Weight Decreased: 13 people, 41.94%
Injection Site Pain: 12 people, 38.71%
Fatigue (feeling of tiredness): 10 people, 32.26%
Fall: 10 people, 32.26%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 32.26%
Pain: 10 people, 32.26%
Joint Pain: 9 people, 29.03%
Hypotension (abnormally low blood pressure): 8 people, 25.81%
Body Temperature Decreased: 8 people, 25.81%
Blood Pressure Systolic Increased: 8 people, 25.81%

What are the existing conditions these people have? *

Type 2 Diabetes: 6 people, 19.35%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 5 people, 16.13%
High Blood Cholesterol: 5 people, 16.13%
Blood Pressure Abnormal: 4 people, 12.90%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.90%
Diabetes: 4 people, 12.90%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 12.90%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 9.68%
Carcinoid Tumor: 3 people, 9.68%
Cardiac Disorder: 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Lopressor and have Injection site mass?

- Check whether Injection site mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopressor:

Lopressor (33,152 reports)

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site mass:

Injection site mass (832 drugs)

Browse all the conditions that are associated with Injection site mass:

Injection site mass (787 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Lopressor) and Lopressor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.